Comparison of the Racial/Ethnic Prevalence of Regular Aspirin Use for the Primary Prevention of Coronary Heart Disease from the Multi-Ethnic Study of Atherosclerosis

In 2002, the United States Preventive Services Task Force and the American Heart Association recommended aspirin for the primary prevention of coronary heart disease in patients with Framingham risk scores ≥6% and ≥10%, respectively. The regular use of aspirin (≥3 days/week) was examined in a cohort...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of cardiology 2011, Vol.107 (1), p.41-46
Hauptverfasser:	Sanchez, Daniel R., MD, Diez Roux, Ana V., MD, PhD, MPH, Michos, Erin D., MD, MHS, Blumenthal, Roger S., MD, Schreiner, Pamela J., PhD, Burke, Gregory L., MD, MSc, Watson, Karol, MD, PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	African Americans Aged Aged, 80 and over Asian Americans Aspirin Aspirin - administration & dosage Atherosclerosis Atherosclerosis (general aspects, experimental research) Biological and medical sciences Blood and lymphatic vessels Cardiology Cardiology. Vascular system Cardiovascular Cardiovascular disease Cohort Studies Comparative analysis Coronary Artery Disease - drug therapy Coronary Artery Disease - ethnology Coronary Artery Disease - prevention & control Coronary heart disease Drug therapy Ethnicity European Continental Ancestry Group Female Follow-Up Studies Heart Hispanic Americans Humans Male Medical sciences Middle Aged Platelet Aggregation Inhibitors - administration & dosage Primary Prevention Race
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In 2002, the United States Preventive Services Task Force and the American Heart Association recommended aspirin for the primary prevention of coronary heart disease in patients with Framingham risk scores ≥6% and ≥10%, respectively. The regular use of aspirin (≥3 days/week) was examined in a cohort of 6,452 White, Black, Hispanic, and Chinese patients without cardiovascular disease in 2000 to 2002 and 5,181 patients from the same cohort in 2005 to 2007. Framingham risk scores were stratified into low (
ISSN:	0002-9149 1879-1913
DOI:	10.1016/j.amjcard.2010.08.041